No photo of Veronica Galvan Hart

View Scopus Profile

Veronica Galvan Hart

  • 4067 Citations
  • 35 h-Index
19982019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Veronica Galvan Hart is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Inhibiting the TOR Pathway to Combat Alzheimer's Disease

Galvan Hart, V.

Project: Research project

Brain cellular senescence as a driver of Alzheimers Disease

Galvan Hart, V.

Project: Research project

Proteomic analysis of Amyloid Precursor Protein signaling: mediators of toxicity

Galvan Hart, V.

Project: Research project

TRAINING GRANT ON THE BIOLOGY OF AGING

Austad, S. N., Musi, N., Pereira-Smith, O. M., Hornsby, P. J. & Galvan Hart, V.

National Institutes of Health

5/1/03 → 4/30/18

Project: Research project

    • Research Output

    • 4067 Citations
    • 35 h-Index
    • 59 Article
    • 4 Review article
    • 2 Editorial
    • 1 Comment/debate

    mTOR drives cerebrovascular, synaptic, and cognitive dysfunction in normative aging

    Van Skike, C. E., Lin, A., Roberts Burbank, R., Halloran, J. J., Hernandez, S. F., Cuvillier, J., Soto, V. Y., Hussong, S. A., Jahrling, J. B., Javors, M. A., Hart, M. J., Fischer, K. E., Austad, S. N. & Galvan, V., Jan 1 2019, (Accepted/In press) In : Aging Cell. e13057.

    Research output: Contribution to journal › Article

    Open Access
    • 2 Scopus citations

    mTOR in cerebrovascular disease

    Van Skike, C. E. & Galvan, V., Mar 15 2019, In : Aging. 11, 5, p. 1331-1332 2 p.

    Research output: Contribution to journal › Editorial

    Obesity in aging exacerbates neuroinflammation, dysregulating synaptic function-related genes and altering eicosanoid synthesis in the mouse hippocampus: Potential role in impaired synaptic plasticity and cognitive decline

    Valcarcel-Ares, M. N., Tucsek, Z., Kiss, T., Giles, C. B., Tarantini, S., Yabluchanskiy, A., Balasubramanian, P., Gautam, T., Galvan, V., Ballabh, P., Richardson, A., Freeman, W. M., Wren, J. D., Deak, F., Ungvari, Z. & Csiszar, A., Feb 15 2019, In : Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 74, 3, p. 290-298 9 p.

    Research output: Contribution to journal › Article

    Open Access
    • 19 Scopus citations

    Rapamycin and Alzheimer's disease: Time for a clinical trial?

    Kaeberlein, M. & Galvan Hart, V., Jan 23 2019, In : Science Translational Medicine. 11, 476, eaar4289.

    Research output: Contribution to journal › Review article

    • 14 Scopus citations

    A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review

    Van Skike, C. E. & Galvan Hart, V., Jan 11 2018, (Accepted/In press) In : Gerontology.

    Research output: Contribution to journal › Article

    • 9 Scopus citations